These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6499219)

  • 1. Analysis of assay errors in drug measurements from the Heathcontrol interlaboratory quality assessment schemes.
    Wilson JF; Newcombe RG; Marshall RW; Williams J; Richens A
    Clin Chim Acta; 1984 Nov; 143(3):203-16. PubMed ID: 6499219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra- and interlaboratory sources of imprecision in drug measurements by different techniques.
    Tsanaclis LM; Wilson JF
    Clin Chem; 1993 May; 39(5):851-5. PubMed ID: 8485875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When should plasma drug levels be monitored?
    Richens A; Warrington S
    Drugs; 1979 Jun; 17(6):488-500. PubMed ID: 467278
    [No Abstract]   [Full Text] [Related]  

  • 4. The 1978 College of American Pathologists Therapeutic Drug Monitoring Interlaboratory Survey Program.
    Juel R
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):306-19. PubMed ID: 474507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum drug concentration assays in clinical practice.
    Buchanan N
    S Afr Med J; 1978 Jan; 53(3):103-5. PubMed ID: 653473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of drug assays.
    Ayers G; Burnett D; Griffiths A; Richens A
    Clin Pharmacokinet; 1981; 6(2):106-17. PubMed ID: 7011655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proficiency test performance as a predictor of accuracy of routine patient testing for theophylline.
    Jenny RW; Jackson KY
    Clin Chem; 1993 Jan; 39(1):76-81. PubMed ID: 8419063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control of drug assays.
    Richens A
    Ciba Found Symp; 1979; (74):69-79. PubMed ID: 261689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. I: Anticonvulsant drugs and theophylline. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):131-9. PubMed ID: 2053120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlaboratory proficiency-testing programs: a computer model to assess their capability to correctly characterize intralaboratory performance.
    Ehrmeyer SS; Laessig RH
    Clin Chem; 1987 Jun; 33(6):784-7. PubMed ID: 3594814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of drugs as a guide to therapy in clinical practice.
    Kelly JG; O'Malley K
    Ir Med J; 1978 Nov; 71(17):578-82. PubMed ID: 721412
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of maintenance dose required to attain a desired drug concentration at steady-state from a single determination of concentration after an initial dose.
    Slattery JT; Gibaldi M; Koup JR
    Clin Pharmacokinet; 1980; 5(4):377-85. PubMed ID: 7398172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
    Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlaboratory variability in determination of serum antidepressive drug concentrations--results of a quality control programme [proceedings].
    Jones S; Turner P
    Br J Clin Pharmacol; 1980 Mar; 9(3):311P. PubMed ID: 7362759
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug level monitoring in paediatric practice.
    Rylance GW; Moreland TA
    Arch Dis Child; 1980 Feb; 55(2):89-98. PubMed ID: 6990880
    [No Abstract]   [Full Text] [Related]  

  • 16. Error models and quality control performance.
    Chiecchio A; Malvano R
    Eur J Clin Chem Clin Biochem; 1996 May; 34(5):423-30. PubMed ID: 8790978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An external quality-control scheme for tricyclic antidepressants.
    Jones S; Turner P
    Postgrad Med J; 1980; 56 Suppl 1():94-8. PubMed ID: 7393835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External quality assessment of Jordanian clinical chemistry laboratories.
    Bilto YY
    Ann Clin Biochem; 1992 May; 29 ( Pt 3)():324-30. PubMed ID: 1610107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control in therapeutic drug monitoring.
    Dijkhuis IC
    Pharm Weekbl Sci; 1988 Aug; 10(4):138-44. PubMed ID: 3174365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies.
    Sonntag O; Scholer A
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):376-85. PubMed ID: 11471880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.